Name
Ascentage Pharma
Company Description
Ascentage Pharma (6855.HK) is a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B, and age-related diseases. Ascentage Pharma focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company has built a pipeline of 9 clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs).
Website
Product Categories (5)
Gastrointestinal (Colorectal) Cancer, Lung Cancer, Melanoma/Skin Cancers, Sarcoma/Bone and Soft Tissue Cancers
Phone (If provided, phone will display online and in-print)
301-291-5658
Address
Rockville, MD
United States
United States